Search Results
Department of Biochemistry (U38-FCT), School of Biotechnology, Faculty of Nutrition and Food Sciences, Animal Facility, Department of Clinical Pathology, ISPUP-EPIUnit, CINTESIS – Center for Research in Health Technologies and Information Systems, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
Search for other papers by Elisa Keating in
Google Scholar
PubMed
Search for other papers by Ana Correia-Branco in
Google Scholar
PubMed
Search for other papers by João R Araújo in
Google Scholar
PubMed
Search for other papers by Manuela Meireles in
Google Scholar
PubMed
Department of Biochemistry (U38-FCT), School of Biotechnology, Faculty of Nutrition and Food Sciences, Animal Facility, Department of Clinical Pathology, ISPUP-EPIUnit, CINTESIS – Center for Research in Health Technologies and Information Systems, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
Search for other papers by Rita Fernandes in
Google Scholar
PubMed
Search for other papers by Luísa Guardão in
Google Scholar
PubMed
Department of Biochemistry (U38-FCT), School of Biotechnology, Faculty of Nutrition and Food Sciences, Animal Facility, Department of Clinical Pathology, ISPUP-EPIUnit, CINTESIS – Center for Research in Health Technologies and Information Systems, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
Department of Biochemistry (U38-FCT), School of Biotechnology, Faculty of Nutrition and Food Sciences, Animal Facility, Department of Clinical Pathology, ISPUP-EPIUnit, CINTESIS – Center for Research in Health Technologies and Information Systems, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
Search for other papers by João T Guimarães in
Google Scholar
PubMed
Search for other papers by Fátima Martel in
Google Scholar
PubMed
Department of Biochemistry (U38-FCT), School of Biotechnology, Faculty of Nutrition and Food Sciences, Animal Facility, Department of Clinical Pathology, ISPUP-EPIUnit, CINTESIS – Center for Research in Health Technologies and Information Systems, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
Search for other papers by Conceição Calhau in
Google Scholar
PubMed
protective effect against colorectal cancer risk ( Sie et al . 2011 ). Metabolic syndrome (MetS) is a condition of high and increasing prevalence worldwide that comprises a constellation of risk factors for cardiovascular disease and type 2 diabetes, such as
Berlin Institute of Health at Charité – Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Berlin, Germany
Search for other papers by Leke Wiering in
Google Scholar
PubMed
Search for other papers by Frank Tacke in
Google Scholar
PubMed
other diseases of the metabolic syndrome and is partly described as its hepatic manifestation. Thus, in the early stages, cardiovascular events represent the main cause of death in NAFLD, whereas in the later stages, liver-associated causes of death as
Search for other papers by Jocemara Patrícia Silva de Souza Parrela in
Google Scholar
PubMed
Search for other papers by Ingridys Regina Borkenhagen in
Google Scholar
PubMed
Search for other papers by Sarah Ramany Faria Salmeron in
Google Scholar
PubMed
Search for other papers by Thalyne Aparecida Leite Lima in
Google Scholar
PubMed
Search for other papers by Ginislene Dias Souza Miranda in
Google Scholar
PubMed
Search for other papers by Hercules de Oliveira Costermani in
Google Scholar
PubMed
Search for other papers by Camila Luiza Rodrigues dos Santos Ricken in
Google Scholar
PubMed
Search for other papers by Ester Vieira Alves in
Google Scholar
PubMed
Search for other papers by Rodrigo Mello Gomes in
Google Scholar
PubMed
Search for other papers by Júlio Cezar de Oliveira in
Google Scholar
PubMed
for infant health, we hypothesized that changes in maternal energy balance, even in the last third of pregnancy, can affect the content of these key hormones in milk, which may be underlying the origin of the metabolic syndrome that is commonly
Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, UK
Search for other papers by Laura L Gathercole in
Google Scholar
PubMed
Search for other papers by Nikolaos Nikolaou in
Google Scholar
PubMed
Search for other papers by Shelley E Harris in
Google Scholar
PubMed
Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, UK
Search for other papers by Anastasia Arvaniti in
Google Scholar
PubMed
Search for other papers by Toryn M Poolman in
Google Scholar
PubMed
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Search for other papers by Jonathan M Hazlehurst in
Google Scholar
PubMed
Search for other papers by Denise V Kratschmar in
Google Scholar
PubMed
Search for other papers by Marijana Todorčević in
Google Scholar
PubMed
Search for other papers by Ahmad Moolla in
Google Scholar
PubMed
Search for other papers by Niall Dempster in
Google Scholar
PubMed
Search for other papers by Ryan C Pink in
Google Scholar
PubMed
Search for other papers by Michael F Saikali in
Google Scholar
PubMed
Search for other papers by Liz Bentley in
Google Scholar
PubMed
Search for other papers by Trevor M Penning in
Google Scholar
PubMed
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Search for other papers by Carolyn L Cummins in
Google Scholar
PubMed
Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, Turku, Finland
Search for other papers by Matti Poutanen in
Google Scholar
PubMed
Search for other papers by Alex Odermatt in
Google Scholar
PubMed
Search for other papers by Roger D Cox in
Google Scholar
PubMed
Search for other papers by Jeremy W Tomlinson in
Google Scholar
PubMed
JM Morton NM Fievet C Kenyon CJ Holmes MC Staels B Seckl JR Mullins JJ 2004 Metabolic syndrome without obesity: hepatic overexpression of 11-hydroxysteroid dehydrogenase type 1 in transgenic mice . PNAS 101 7088 – 7093 . ( https
Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, Salamanca, Spain
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, Salamanca, Spain
Search for other papers by L Francisco Lorenzo-Martín in
Google Scholar
PubMed
Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, Salamanca, Spain
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, Salamanca, Spain
Search for other papers by Mauricio Menacho-Márquez in
Google Scholar
PubMed
Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, Salamanca, Spain
Search for other papers by Salvatore Fabbiano in
Google Scholar
PubMed
Centro de Investigación en Medicina Molecular e Enfermidades Crónicas, University of Santiago de Compostela, Santiago de Compostela, Spain
Centro de Investigación Biomédica en Red de Cáncer sobre la Fisiopatología de la Obesidad y Nutrición (CIBEROBN), University of Santiago de Compostela, Santiago de Compostela, Spain
Search for other papers by Omar Al-Massadi in
Google Scholar
PubMed
Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, Salamanca, Spain
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, Salamanca, Spain
Search for other papers by Antonio Abad in
Google Scholar
PubMed
Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, Salamanca, Spain
Search for other papers by Sonia Rodríguez-Fdez in
Google Scholar
PubMed
Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, Salamanca, Spain
Search for other papers by María A Sevilla in
Google Scholar
PubMed
Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, Salamanca, Spain
Search for other papers by María J Montero in
Google Scholar
PubMed
Centro de Investigación en Medicina Molecular e Enfermidades Crónicas, University of Santiago de Compostela, Santiago de Compostela, Spain
Centro de Investigación Biomédica en Red de Cáncer sobre la Fisiopatología de la Obesidad y Nutrición (CIBEROBN), University of Santiago de Compostela, Santiago de Compostela, Spain
Search for other papers by Carlos Diéguez in
Google Scholar
PubMed
Centro de Investigación en Medicina Molecular e Enfermidades Crónicas, University of Santiago de Compostela, Santiago de Compostela, Spain
Centro de Investigación Biomédica en Red de Cáncer sobre la Fisiopatología de la Obesidad y Nutrición (CIBEROBN), University of Santiago de Compostela, Santiago de Compostela, Spain
Search for other papers by Rubén Nogueiras in
Google Scholar
PubMed
Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, Salamanca, Spain
Search for other papers by Xosé R Bustelo in
Google Scholar
PubMed
case of borderline hypertension, neurogenic hypertension and the metabolic syndrome ( Moller & Kaufman 2005 , Mancia et al. 2007 , Lambert et al. 2010 ). This latter multiorgan spanning disease, together with the high incidence of sympathomimetic
Search for other papers by Malin Hedengran Faulds in
Google Scholar
PubMed
Search for other papers by Chunyan Zhao in
Google Scholar
PubMed
Search for other papers by Karin Dahlman-Wright in
Google Scholar
PubMed
Search for other papers by Jan-Åke Gustafsson in
Google Scholar
PubMed
–calmodulin-dependent kinases or activation of MAP kinase and phosphoinositide 3-kinase pathways. Estrogen signaling and metabolic syndrome The metabolic syndrome refers to a group of interrelated metabolic abnormalities that include disturbed glucose homeostasis, insulin
Search for other papers by Giselle Adriana Abruzzese in
Google Scholar
PubMed
Search for other papers by Maria Florencia Heber in
Google Scholar
PubMed
Search for other papers by Silvana Rocio Ferreira in
Google Scholar
PubMed
Search for other papers by Leandro Martin Velez in
Google Scholar
PubMed
Search for other papers by Roxana Reynoso in
Google Scholar
PubMed
Search for other papers by Omar Pedro Pignataro in
Google Scholar
PubMed
Search for other papers by Alicia Beatriz Motta in
Google Scholar
PubMed
hyperandrogenism, is related to hyperinsulinemia, dyslipidemia, insulin resistance (IR), cardiovascular disease and metabolic syndrome ( Demissie et al . 2008 , Amalfi et al . 2012 , Heber et al . 2013 ). However, how fetal programming impacts on different
Search for other papers by Chiung-Kuei Huang in
Google Scholar
PubMed
Search for other papers by Soo Ok Lee in
Google Scholar
PubMed
Department of Medicine, Case Cardiovascular Institute Research Institute, Case Western Reserve University, Cleveland, OH, USA
Search for other papers by Eugene Chang in
Google Scholar
PubMed
Search for other papers by Haiyan Pang in
Google Scholar
PubMed
Sex Hormone Research Center, China Medical University/Hospital, Taichung, Taiwan
Search for other papers by Chawnshang Chang in
Google Scholar
PubMed
, suggesting the androgen levels might need to be balanced. Therefore, androgen/AR signaling might not be the suitable therapeutic target in heart failure patients. AR effects on the metabolic syndrome/diabetes and their impacts on CVDs Earlier we
Search for other papers by Jie Wei in
Google Scholar
PubMed
Search for other papers by Xia Sun in
Google Scholar
PubMed
Search for other papers by Yajie Chen in
Google Scholar
PubMed
Search for other papers by Yuanyuan Li in
Google Scholar
PubMed
Search for other papers by Liqiong Song in
Google Scholar
PubMed
Search for other papers by Zhao Zhou in
Google Scholar
PubMed
Search for other papers by Bing Xu in
Google Scholar
PubMed
Search for other papers by Yi Lin in
Google Scholar
PubMed
Search for other papers by Shunqing Xu in
Google Scholar
PubMed
Introduction Nonalcoholic fatty liver disease (NAFLD) is one of the typical hepatic manifestations of metabolic syndrome characterized by hepatic fat accumulation in the absence of excess alcohol consumption. NAFLD affects 15–40% of the general
Search for other papers by Fiona Roberts in
Google Scholar
PubMed
Search for other papers by Greg Markby in
Google Scholar
PubMed
Search for other papers by Scott Dillon in
Google Scholar
PubMed
Search for other papers by Colin Farquharson in
Google Scholar
PubMed
Search for other papers by Vicky E MacRae in
Google Scholar
PubMed
. 1996 , Kirsch et al. 1997 , Nielsen et al. 2001 , Yoshiko et al. 2007 , Golub 2009 , Bourgine et al. 2011 ). Metabolic syndrome Metabolic syndrome is a global epidemic, with rates increasing alarmingly across both developed and